MEGF9

A novel transmembrane protein with a strong and developmentally regulated expression in the nervous system

Ulrike Brandt-Bohne, Douglas R. Keene, Fletcher White, Manuel Koch

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

MEGF9 [multiple EGF (epidermal growth factor)-like-domains 9], a novel transmembrane protein with multiple EGF-like repeats, is predominantly expressed in the developing and adult CNS (central nervous system) and PNS (peripheral nervous system). The domain structure of MEGF9 consists of an N-terminal region with several potential O-glycosylation sites followed by five EGF-like domains, which are highly homologous with the short arms of laminins. Following one single pass transmembrane domain, a highly conserved short intracellular domain with potential phosphorylation sites is present. The protein was recombinantly expressed and characterized as a tissue component. To study the expression pattern further, immunohistochemistry was performed and staining was detected in Purkinje cells of the cerebellum and in glial cells of the PNS. Additional expression was observed in the epidermal layer of skin, papillae of the tongue and the epithelium of the gastrointestinal tract. By immunoelectron microscopy, MEGF9 was detected in glial cells of the sciatic nerve facing the basement membrane. MEGF9 represents a novel putative receptor, expressed in neuronal and non-neuronal tissues, that is regulated during development and could function as a guidance or signalling molecule.

Original languageEnglish (US)
Pages (from-to)447-457
Number of pages11
JournalBiochemical Journal
Volume401
Issue number2
DOIs
StatePublished - Jan 15 2007
Externally publishedYes

Fingerprint

Neurology
Epidermal Growth Factor
Nervous System
Peripheral Nervous System
Neuroglia
Tissue
Glycosylation
Phosphorylation
Proteins
Immunoelectron Microscopy
Purkinje Cells
Laminin
Sciatic Nerve
Tongue
Basement Membrane
Cerebellum
Gastrointestinal Tract
Skin
Microscopic examination
Arm

Keywords

  • Glial cell
  • Glycosylation
  • MEGF9
  • Nervous system
  • Skin
  • Transmembrane protein

ASJC Scopus subject areas

  • Biochemistry

Cite this

MEGF9 : A novel transmembrane protein with a strong and developmentally regulated expression in the nervous system. / Brandt-Bohne, Ulrike; Keene, Douglas R.; White, Fletcher; Koch, Manuel.

In: Biochemical Journal, Vol. 401, No. 2, 15.01.2007, p. 447-457.

Research output: Contribution to journalArticle

Brandt-Bohne, Ulrike ; Keene, Douglas R. ; White, Fletcher ; Koch, Manuel. / MEGF9 : A novel transmembrane protein with a strong and developmentally regulated expression in the nervous system. In: Biochemical Journal. 2007 ; Vol. 401, No. 2. pp. 447-457.
@article{2586d902a62746659eac30f2f4c5903f,
title = "MEGF9: A novel transmembrane protein with a strong and developmentally regulated expression in the nervous system",
abstract = "MEGF9 [multiple EGF (epidermal growth factor)-like-domains 9], a novel transmembrane protein with multiple EGF-like repeats, is predominantly expressed in the developing and adult CNS (central nervous system) and PNS (peripheral nervous system). The domain structure of MEGF9 consists of an N-terminal region with several potential O-glycosylation sites followed by five EGF-like domains, which are highly homologous with the short arms of laminins. Following one single pass transmembrane domain, a highly conserved short intracellular domain with potential phosphorylation sites is present. The protein was recombinantly expressed and characterized as a tissue component. To study the expression pattern further, immunohistochemistry was performed and staining was detected in Purkinje cells of the cerebellum and in glial cells of the PNS. Additional expression was observed in the epidermal layer of skin, papillae of the tongue and the epithelium of the gastrointestinal tract. By immunoelectron microscopy, MEGF9 was detected in glial cells of the sciatic nerve facing the basement membrane. MEGF9 represents a novel putative receptor, expressed in neuronal and non-neuronal tissues, that is regulated during development and could function as a guidance or signalling molecule.",
keywords = "Glial cell, Glycosylation, MEGF9, Nervous system, Skin, Transmembrane protein",
author = "Ulrike Brandt-Bohne and Keene, {Douglas R.} and Fletcher White and Manuel Koch",
year = "2007",
month = "1",
day = "15",
doi = "10.1042/BJ20060691",
language = "English (US)",
volume = "401",
pages = "447--457",
journal = "Biochemical Journal",
issn = "0264-6021",
publisher = "Portland Press Ltd.",
number = "2",

}

TY - JOUR

T1 - MEGF9

T2 - A novel transmembrane protein with a strong and developmentally regulated expression in the nervous system

AU - Brandt-Bohne, Ulrike

AU - Keene, Douglas R.

AU - White, Fletcher

AU - Koch, Manuel

PY - 2007/1/15

Y1 - 2007/1/15

N2 - MEGF9 [multiple EGF (epidermal growth factor)-like-domains 9], a novel transmembrane protein with multiple EGF-like repeats, is predominantly expressed in the developing and adult CNS (central nervous system) and PNS (peripheral nervous system). The domain structure of MEGF9 consists of an N-terminal region with several potential O-glycosylation sites followed by five EGF-like domains, which are highly homologous with the short arms of laminins. Following one single pass transmembrane domain, a highly conserved short intracellular domain with potential phosphorylation sites is present. The protein was recombinantly expressed and characterized as a tissue component. To study the expression pattern further, immunohistochemistry was performed and staining was detected in Purkinje cells of the cerebellum and in glial cells of the PNS. Additional expression was observed in the epidermal layer of skin, papillae of the tongue and the epithelium of the gastrointestinal tract. By immunoelectron microscopy, MEGF9 was detected in glial cells of the sciatic nerve facing the basement membrane. MEGF9 represents a novel putative receptor, expressed in neuronal and non-neuronal tissues, that is regulated during development and could function as a guidance or signalling molecule.

AB - MEGF9 [multiple EGF (epidermal growth factor)-like-domains 9], a novel transmembrane protein with multiple EGF-like repeats, is predominantly expressed in the developing and adult CNS (central nervous system) and PNS (peripheral nervous system). The domain structure of MEGF9 consists of an N-terminal region with several potential O-glycosylation sites followed by five EGF-like domains, which are highly homologous with the short arms of laminins. Following one single pass transmembrane domain, a highly conserved short intracellular domain with potential phosphorylation sites is present. The protein was recombinantly expressed and characterized as a tissue component. To study the expression pattern further, immunohistochemistry was performed and staining was detected in Purkinje cells of the cerebellum and in glial cells of the PNS. Additional expression was observed in the epidermal layer of skin, papillae of the tongue and the epithelium of the gastrointestinal tract. By immunoelectron microscopy, MEGF9 was detected in glial cells of the sciatic nerve facing the basement membrane. MEGF9 represents a novel putative receptor, expressed in neuronal and non-neuronal tissues, that is regulated during development and could function as a guidance or signalling molecule.

KW - Glial cell

KW - Glycosylation

KW - MEGF9

KW - Nervous system

KW - Skin

KW - Transmembrane protein

UR - http://www.scopus.com/inward/record.url?scp=33846541348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846541348&partnerID=8YFLogxK

U2 - 10.1042/BJ20060691

DO - 10.1042/BJ20060691

M3 - Article

VL - 401

SP - 447

EP - 457

JO - Biochemical Journal

JF - Biochemical Journal

SN - 0264-6021

IS - 2

ER -